Cargando…
Increased C reactive protein, cardiac troponin I and GLS are associated with myocardial inflammation in patients with non-ischemic heart failure
Inflammatory cardiomyopathy diagnosed by endomyocardial biopsy (EMB) is common in non-ischemic heart failure (HF) and might be associated with adverse outcome. We aimed to identify markers predicting myocardial inflammation in HF. We screened 517 patients with symptomatic non-ischemic HF who underwe...
Autores principales: | Schwuchow-Thonke, S., Göbel, S., Emrich, T., Schmitt, V. H., Fueting, F., Klank, C., Escher, F., Schultheiss, H. P., Münzel, T., Keller, K., Wenzel, P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7862434/ https://www.ncbi.nlm.nih.gov/pubmed/33542341 http://dx.doi.org/10.1038/s41598-021-82592-8 |
Ejemplares similares
-
Safety of transradial and transfemoral left ventricular compared with transfemoral right ventricular endomyocardial biopsy
por: Göbel, Sebastian, et al.
Publicado: (2020) -
Multiomics Analysis Reveals that GLS and GLS2 Differentially Modulate the Clinical Outcomes of Cancer
por: Saha, Subbroto Kumar, et al.
Publicado: (2019) -
Silencing of GLS and overexpression of GLS2 genes cooperate in decreasing the proliferation and viability of glioblastoma cells
por: Szeliga, Monika, et al.
Publicado: (2013) -
Identification of GLS as a cuproptosis-related diagnosis gene in acute myocardial infarction
por: Liu, Zheng, et al.
Publicado: (2022) -
The impact of platelet indices on clinical outcome in heart failure: results from the MyoVasc study
por: Dahlen, Bianca, et al.
Publicado: (2021)